comparemela.com

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress

Card image cap

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Texas , United States , North Carolina , Spain , Madrid , Lini Pandite , Samer Zeidan , Conor Richardson , Exchange Commission , Shattuck Labs Inc , Nasdaq , Chief Medical Officer , Bi Functional Fusion Protein Targeting , Previously Untreated Acute Myeloid Leukemia , Higher Risk Myelodysplastic , Shattuck Labs , Agonist Redirected Checkpoint , Annual Report , Safe Harbor , Private Securities Litigation Reform Act , Media Contact ,

comparemela.com © 2020. All Rights Reserved.